Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine ER in moderate-to-severe Alzheimer's disease
NCT00322153Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Jun 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of memantine in Alzheimer's disease (AD), sponsored by Forest Laboratories. Started Jun 2005; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00322153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00322153.